Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000435930 | SCV000536665 | uncertain significance | not provided | 2017-02-06 | criteria provided, single submitter | clinical testing | The V1014M variant in the LIPE gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. This variant is observed in 4/246 (1.63%) alleles from individuals of Latino background, in the ExAC dataset (Lek et al., 2016). The V1014M variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret V1014M as a variant of uncertain significance. |
Baylor Genetics | RCV001330054 | SCV001521645 | uncertain significance | LIPE-related familial partial lipodystrophy | 2019-08-21 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Breakthrough Genomics, |
RCV000435930 | SCV005194660 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003942463 | SCV004760217 | likely benign | LIPE-related disorder | 2020-08-10 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |